With this approval, the MiniMed™ 780G system now offers more flexibility for users of the company's most advanced insulin delivery system featuring Meal Detection™ technology with both the ...

A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments. Objectives: Advances in diabetes technology have led ...

Following a U.S. commercial rollout slated for this fall, it will be able to link with Medtronic’s MiniMed 780G insulin pump. Currently, people with diabetes can use the MiniMed 780G with the ...

Medtronic plc has announced the U.S. Food and Drug Administration (FDA) has approved the Simplera Sync sensor for use with the MiniMed 780G system. With this approval, the MiniMed 780G system now ...

In its application to the Food and Drug Administration, Medtronic is seeking clearance for its MiniMed 780G pump as an alternate controller-enabled insulin pump. If approved, the pump would be ...

With this approval, the MiniMed™ 780G system now offers more flexibility for users of the company's most advanced insulin delivery system featuring Meal Detection™ technology with both the Guardian™ 4 ...

(RTTNews) - Medtronic plc. (MDT) announced the U.S. Food and Drug Administration approval for the Simplera Sync sensor for use with the MiniMed 780G system. The MiniMed 780G system now offers more ...

Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced ...